US 11608335
Somatostatin modulators and uses thereof
granted A61PA61P3/08
Quick answer
US patent 11608335 (Somatostatin modulators and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRINETICS PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P3/08